A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects
Phase of Trial: Phase IV
Latest Information Update: 26 Jun 2019
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Abacavir; Antiretrovirals; Didanosine; Efavirenz; Emtricitabine; Lamivudine; Stavudine; Zidovudine
- Indications HIV-1 infections
- Focus Adverse reactions
- Acronyms HIV
- Sponsors Gilead Sciences
- 07 Mar 2019 Results presented at the 26th Conference on Retroviruses and Opportunistic Infections
- 30 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Feb 2014 Planned End Date changed from 22 Jun 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov record.